Desjardins Global Asset Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,177
Closed -$313K 700
2023
Q3
$313K Buy
9,177
+2,994
+48% +$114K 0.03% 310
2023
Q2
$247K Buy
6,183
+132
+2% +$5.25K 0.03% 405
2023
Q1
$238K Sell
6,051
-485
-7% -$17.8K 0.03% 382
2022
Q4
$208K Buy
6,536
+728
+13% +$21.9K 0.03% 338
2022
Q3
$164K Sell
5,808
-525
-8% -$17.9K 0.02% 359
2022
Q2
$226K Hold
6,333
0.03% 337
2022
Q1
$311K Sell
6,333
-157
-2% -$8.3K 0.03% 317
2021
Q4
$362K Buy
+6,490
New +$357K 0.03% 312

Other funds holding XRAY

Desjardins Global Asset Management's XRAY Position: Q4 2023 in Review

Desjardins Global Asset Management sold out of Dentsply Sirona (XRAY) in Q4 2023, closing a stake of 9,177 shares — an estimated $313K sold.

Desjardins Global Asset Management first reported a position in XRAY in Q4 2021 and held it in 8 quarters. The position peaked at $362K in Q4 2021. 416 funds tracked by Wall St. Rank hold XRAY as of Q4 2023.

  • Desjardins Global Asset Management reported no remaining Dentsply Sirona position as of Q4 2023 after selling out during the quarter.
  • Desjardins Global Asset Management sold 9,177 Dentsply Sirona shares in Q4 2023, an estimated $313K.
  • Desjardins Global Asset Management first reported a position in Dentsply Sirona in Q4 2021 and held it in 8 quarters.
  • Desjardins Global Asset Management's Dentsply Sirona position peaked at $362K in Q4 2021.
  • 416 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.